Metabolic Nutrition: Diet–Microbiota Interactions in Obesity and Inflammation

A special issue of Life (ISSN 2075-1729). This special issue belongs to the section "Microbiology".

Deadline for manuscript submissions: closed (16 April 2026) | Viewed by 1588

Special Issue Editors


E-Mail Website
Guest Editor
1. Department of Agricultural, Food and Nutritional Science, University of Alberta, Edmonton, AB T6G 2P5, Canada
2. Department of Physiology, University of Alberta, Edmonton, AB T6G 2H7, Canada
Interests: obesity and type 2 diabetes

E-Mail Website
Guest Editor
Department of Biology, University of British Columbia—Okanagan Campus, Kelowna, BC V1V 1V7, Canada
Interests: microbiome; nutrition; inflammation; metabolic diseases

Special Issue Information

Dear Colleagues,

The rise in obesity and related diseases is linked to chronic low-grade inflammation. Studies highlight the importance of diet–microbiota interactions in the development of obesity and inflammation. The consequences of obesity result not only from issues with calorie balance but also from gut microbial dysbiosis—an imbalance in the intestinal microbiota associated with increased energy extraction, gut permeability, and inflammation, factors that contribute to metabolic diseases such as type 2 diabetes, heart disease, and NAFLD/MASLD.

Diet is a well-established factor that influences the structure and function of the gut microbiome. Consuming foods high in fats and sugars tends to increase the pro-inflammatory state. In contrast, consuming a diet rich in fiber helps to support beneficial microbes that produce short-chain fatty acids. These fatty acids play a crucial role in maintaining gut barrier health, supporting immune responses, and regulating energy metabolism. Nutrition in early life, such as breastfeeding and initial dietary habits, sets the stage for lifelong microbial patterns that can influence the risk of obesity, highlighting important periods for preventive care. Personalized nutrition based on an individual microbiome offers exciting possibilities for targeted health interventions. Additionally, using probiotics, prebiotics, and synbiotics together can further enhance body composition and reduce inflammation across diverse populations.

Despite these advances, critical gaps persist. This Special Issue, therefore, invites cutting-edge contributions spanning molecular, clinical, and computational perspectives. We invite original research, reviews, meta-analyses, brief communications, and methodological papers exploring the following:

  1. Impacts of dietary components or patterns on gut microbiota and their effects on obesity and inflammation;
  2. Mechanisms via which gut microbiota influences host metabolism and inflammatory pathways;
  3. Interventions targeting gut microbiota (e.g., diet, probiotics, prebiotics, fecal microbiota transplantation) to prevent or treat obesity and inflammation;
  4. Diet–microbiota interactions across life stages, particularly in children and adolescents;
  5. Translational research, including personalized nutrition based on microbiota profiling;
  6. Leveraging multi-omics, machine learning, or systems biology to integrate diet, microbiome, and host phenotypes.

Prof. Dr. Catherine Chan
Dr. Emad Yuzbashian
Guest Editors

Manuscript Submission Information

Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 250 words) can be sent to the Editorial Office for assessment.

Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Life is an international peer-reviewed open access monthly journal published by MDPI.

Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2600 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.

Keywords

  • nutrition
  • dietary intake
  • microbiome
  • inflammation

Benefits of Publishing in a Special Issue

  • Ease of navigation: Grouping papers by topic helps scholars navigate broad scope journals more efficiently.
  • Greater discoverability: Special Issues support the reach and impact of scientific research. Articles in Special Issues are more discoverable and cited more frequently.
  • Expansion of research network: Special Issues facilitate connections among authors, fostering scientific collaborations.
  • External promotion: Articles in Special Issues are often promoted through the journal's social media, increasing their visibility.
  • Reprint: MDPI Books provides the opportunity to republish successful Special Issues in book format, both online and in print.

Further information on MDPI's Special Issue policies can be found here.

Published Papers (1 paper)

Order results
Result details
Select all
Export citation of selected articles as:

Review

20 pages, 317 KB  
Review
Diet, Physical Exercise, and Gut Microbiota Modulation in Metabolic Syndrome: A Narrative Review
by Ana Onu, Andrei Tutu, Daniela-Marilena Trofin, Ilie Onu, Anca-Irina Galaction, Cristiana Amalia Onita, Daniel-Andrei Iordan and Daniela-Viorelia Matei
Life 2026, 16(1), 98; https://doi.org/10.3390/life16010098 - 10 Jan 2026
Cited by 4 | Viewed by 1303
Abstract
Background: Metabolic syndrome (MetS) is a multifactorial condition characterized by insulin resistance, dyslipidemia, hypertension, and central obesity, and is strongly influenced by lifestyle factors. Growing evidence highlights the gut microbiota as a key mediator linking diet and physical exercise to cardiometabolic health. Objective: [...] Read more.
Background: Metabolic syndrome (MetS) is a multifactorial condition characterized by insulin resistance, dyslipidemia, hypertension, and central obesity, and is strongly influenced by lifestyle factors. Growing evidence highlights the gut microbiota as a key mediator linking diet and physical exercise to cardiometabolic health. Objective: This narrative review aims to qualitatively synthesize current evidence on the effects of physical exercise and major dietary patterns including the Mediterranean diet (MedDiet), Dietary Approaches to Stop Hypertension (DASH), and ketogenic/very-low-calorie ketogenic diets (KD/VLCKD) on gut microbiota composition and function, and their implications for metabolic health in MetS. Methods: A qualitative narrative synthesis of experimental, observational, and interventional human and animal studies was performed. The reviewed literature examined associations between structured physical exercise or dietary interventions and changes in gut microbiota diversity, key bacterial taxa, microbial metabolites, and cardiometabolic outcomes. Considerable heterogeneity across studies was noted, including differences in populations, intervention duration and intensity, dietary composition, and microbiota assessment methodologies. Results: Across human interventional studies, moderate-intensity physical exercise was most consistently associated with increased gut microbial diversity and enrichment of short-chain fatty acid (SCFA)-producing taxa, contributing to improved insulin sensitivity and reduced inflammation. MedDiet and DASH were generally linked to favorable microbiota profiles, including increased abundance of Faecalibacterium prausnitzii, Akkermansia muciniphila, and Bifidobacterium, alongside reductions in pro-inflammatory metabolites such as lipopolysaccharides and trimethylamine N-oxide. In contrast, KD and VLCKD were associated with rapid weight loss and glycemic improvements but frequently accompanied by reductions in SCFA-producing bacteria, depletion of Bifidobacterium, and markers of impaired gut barrier integrity, raising concerns regarding long-term microbiota resilience. Conclusions: Lifestyle-based interventions exert diet- and exercise-specific effects on the gut microbiota–metabolism axis. While MedDiet, DASH, and regular moderate physical activity appear to promote sustainable microbiota-mediated cardiometabolic benefits, ketogenic approaches require careful personalization, limited duration, and medical supervision. These findings support the integration of dietary quality, exercise prescription, and individual microbiota responsiveness into translational lifestyle strategies for MetS prevention and management. Full article
Back to TopTop